Drugs / Wilhelmina®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05799053 | May 2022 → Nov 2024 | irritable bowel syndrome | St. Antonius Hospital | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wilhelmina | “Wilhelmina® peppermints contain 9.2 mg of Menthae Piperitae Aetheroleum (peppermint oil), and 18.4 Kcal per mint and are to be taken orally.” NCT05799053 ↗ |
| Known as | Peppermint sweets | “Peppermint sweets (Wilhelmina®)” NCT05799053 ↗ |
| Route | Oral | “are to be taken orally” NCT05799053 ↗ |